| Bibliographic Citation
| - Rusakiewicz Sylvie, Perier Aurelie, Semeraro Michaela, Pitt Jonathan M., Strandmann Elke Pogge, Reiners Katrin S., Aspeslagh Sandrine, Piperoglou Christelle, Vely Frederic, Ivagnes Alexandre, Jegou Sarah, Halama Niels, Chaigneau Loic, Validire Pierre, Christidis Christos, Perniceni Thierry, Landi Bruno, Berger Anne, Isambert Nicolas, Domont Julien, Bonvalot Sylvie, Terrier Philippe, Adam Julien, Coindre Jean-Michel, Emile Jean-Francois, Poirier-Colame Vichnou, Chaba Kariman, Rocha Benedita, Caignard Anne, Toubert Antoine, Enot David, Koch Joachim, Marabelle Aurelien, Lambert Marion, Caillat-Zucman Sophie, Leyvraz Serge, Auclair Christian, Vivier Eric, Eggermont Alexander, Borg Christophe, Blay Jean-Yves, Le Cesne Axel, Mir Olivier, Zitvogel Laurence. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. OncoImmunology, Taylor & Francis, 2017, 6 (1), ⟨10.1080/2162402X.2015.1137418⟩
- Rusakiewicz Sylvie, Semeraro Michaela, Pitt Jonathan M., Aspeslagh Sandrine, Piperoglou Christelle, Vely Frederic, Ivagnes Alexandre, Jegou Sarah, Chaigneau Loic, Validire Pierre, Christidis Christos, Perniceni Thierry, Landi Bruno, Isambert Nicolas, Domont Julien, Terrier Philippe, Adam Julien, Coindre Jean-Michel, Emile Jean-Francois, Poirier-Colame Vichnou, Chaba Kariman, Rocha Benedita, Caignard Anne, Toubert Antoine, Enot David, Koch Joachim, Marabelle Aurelien, Caillat-Zucman Sophie, Auclair Christian, Vivier Eric, Eggermont Alexander, Borg Christophe, Blay Jean-Yves, Le Cesne Axel, Mir Olivier, Zitvogel Laurence. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. OncoImmunology, Taylor & Francis, 2017, 6 (1), ⟨10.1080/2162402X.2015.1137418⟩
- RusakiewiczSylvie, PerierAurelie, SemeraroMichaela, PittJonathan M., StrandmannElke Pogge, ReinersKatrin S., AspeslaghSandrine, PiperoglouChristelle, VelyFrederic, IvagnesAlexandre, JegouSarah, HalamaNiels, ChaigneauLoic, ValidirePierre, ChristidisChristos, PerniceniThierry, LandiBruno, BergerAnne, IsambertNicolas, DomontJulien, BonvalotSylvie, TerrierPhilippe, AdamJulien, CoindreJean-Michel, EmileJean-Francois, Poirier-ColameVichnou, ChabaKariman, RochaBenedita, CaignardAnne, ToubertAntoine, EnotDavid, KochJoachim, MarabelleAurelien, LambertMarion, Caillat-ZucmanSophie, LeyvrazSerge, AuclairChristian, VivierEric, EggermontAlexander, BorgChristophe, BlayJean-Yves, Le CesneAxel, MirOlivier, ZitvogelLaurence . NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients . OncoImmunology, 2017, 6 (1), ⟨10.1080/2162402X.2015.1137418⟩
- Rusakiewicz Sylvie, Semeraro Michaela, Pitt Jonathan M., Aspeslagh Sandrine, Piperoglou Christelle, Vely Frederic, Ivagnes Alexandre, Jegou Sarah, Chaigneau Loic, Validire Pierre, Christidis Christos, Perniceni Thierry, Landi Bruno, Isambert Nicolas, Domont Julien, Terrier Philippe, Adam Julien, Coindre Jean-Michel, Emile Jean-Francois, Poirier-Colame Vichnou, Chaba Kariman, Rocha Benedita, Caignard Anne, Toubert Antoine, Enot David, Koch Joachim, Marabelle Aurelien, Caillat-Zucman Sophie, Auclair Christian, Vivier Eric, Eggermont Alexander, Borg Christophe, Blay Jean-Yves, Le Cesne Axel, Mir Olivier, Zitvogel Laurence . NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients . OncoImmunology, 2017, 6 (1), ⟨10.1080/2162402X.2015.1137418⟩
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
